Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Food and Drug...

    Tag: food and drug administration

    You Searched For "Food and Drug Administration"
    Somatropin approved for most stature related Pediatric Indications

    Somatropin approved for most stature related Pediatric Indications

    Vinay Singh singh22 July 2018 7:15 PM IST
    Zomacton (somatropin) was approved by the Food and Drug Administration (FDA) for the treatment of pediatric patients with idiopathic short stature...
    Long-acting injectable treatment of schizophrenia Approved

    Long-acting injectable treatment of schizophrenia Approved

    Hina Zahid28 July 2018 7:25 PM IST
    The U.S. Food and Drug Administration (FDA) has approved PERSERIS™, the first once-monthly subcutaneous risperidone-containing, long-acting injectable...
    Azithromycin may lead to relapse in certain cancer patients-FDA Alert

    Azithromycin may lead to relapse in certain cancer patients-FDA Alert

    Vinay Singh singh6 Aug 2018 7:05 PM IST
    Issuing a safety alert, the Food and Drug Administration (FDA) warned not to use azithromycin as a prophylactic immunomodulatory agent to prevent...
    Omalizumab good at preventing food allergies after accidental exposure

    Omalizumab good at preventing food allergies after accidental exposure

    Medha Baranwal Baranwal16 Aug 2018 8:10 PM IST
    Omalizumab may be a breakthrough therapy for preventing food allergies and consequent reactions after accidental exposure of offending foods.The U.S....
    First new upfront treatment Unresectable Liver Cancer

    First new upfront treatment Unresectable Liver Cancer

    Dr. Kamal Kant Kohli Kohli16 Aug 2018 7:05 PM IST
    Lenvatinib capsules have been approved (Lenvima, Eisai Inc.) as first-line treatment of patients with unresectable Liver Cancer or hepatocellular...
    Researchers develop new drugs to help quit smoking

    Researchers develop new drugs to help quit smoking

    Vinay Singh singh29 Aug 2018 7:10 PM IST
    Researchers created a more than a dozen candidate drugs to help quit smoking as they have the potential to curb smokers' desire for nicotine by...
    Eravacycline-Latest antibiotic for complicated intra-abdominal infections

    Eravacycline-Latest antibiotic for complicated intra-abdominal infections

    Vinay Singh singh29 Aug 2018 8:28 PM IST
    Xerava, Eravacycline injection secured approval from the US Food and Drug Administration (FDA) for the treatment of complicated intra-abdominal...
    SGLT2 inhibitors may cause Fourniers gangrene of genital area in diabetics : FDA warns

    SGLT2 inhibitors may cause Fournier's gangrene of genital area in diabetics : FDA warns

    Hina Zahid31 Aug 2018 8:35 PM IST
    The Food and Drug Administration (FDA) has issued a warning regarding serious genital infection known as Fournier's gangrene that has been reported in...
    FDA approves new dosage of buprenorphine and naloxone for opioid dependence

    FDA approves new dosage of buprenorphine and naloxone for opioid dependence

    Hina Zahid8 Sept 2018 7:20 PM IST
    The U.S. Food and Drug Administration today approved Cassipa (buprenorphine and naloxone) sublingual film (applied under the tongue) for the...
    Tezepelumab designated as breakthrough therapy for Severe Asthma

    Tezepelumab designated as breakthrough therapy for Severe Asthma

    Vinay Singh singh11 Sept 2018 8:20 PM IST
    The U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for tezepelumab in patients with severe asthma without an...
    Tenapanor effective for Irritable Bowel Syndrome With Constipation

    Tenapanor effective for Irritable Bowel Syndrome With Constipation

    Vinay Singh singh17 Sept 2018 7:25 PM IST
    Food and Drug Administration received the New Drug Application (NDA) for tenapanor, an investigational treatment for irritable bowel syndrome with...
    FDA approves latanoprost emulsion for Glaucoma

    FDA approves latanoprost emulsion for Glaucoma

    Hina Zahid18 Sept 2018 7:30 PM IST
    The Food and Drug Administration has approved Latanoprost ophthalmic emulsion 0.005% for the reduction of elevated intraocular pressure (IOP) in...
    PrevNext

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 12 Oct 2022 7:06 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok